7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To examine the effects of interferon beta (IFNβ)-1b on all-cause mortality over 21 years in the cohort of 372 patients who participated in the pivotal randomized clinical trial (RCT), retaining (in the analysis) the original randomized treatment-assignments.

          Related collections

          Author and article information

          Journal
          Neurology
          Neurology
          Ovid Technologies (Wolters Kluwer Health)
          1526-632X
          0028-3878
          Apr 24 2012
          : 78
          : 17
          Affiliations
          [1 ] Department of Neurology, University of California, San Francisco, CA, USA. douglas.goodin@ucsf.edu
          Article
          WNL.0b013e3182535cf6
          10.1212/WNL.0b013e3182535cf6
          3335454
          22496198
          a8682a45-0742-452f-be08-920932220777
          History

          Comments

          Comment on this article